tiprankstipranks
Trending News
More News >
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market

Bicara Therapeutics Inc. (BCAX) Technical Analysis

Compare
70 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Bicara Therapeutics Inc.’s (BCAX) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Bicara Therapeutics Inc. is a Buy.
Bicara Therapeutics Inc.’s (BCAX) 20-Day exponential moving average is 17.71, while Bicara Therapeutics Inc.’s (BCAX) share price is $17.27, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) 50-Day exponential moving average is 16.89, while Bicara Therapeutics Inc.’s (BCAX) share price is $17.27, making it a Sell.

Bicara Therapeutics Inc. (BCAX) Pivot Points

Dec 27, 2025, 06:03 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.54
16.89
17.08
17.44
17.62
17.98
18.17
Fibonacci
16.89
17.10
17.23
17.44
17.64
17.77
17.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bicara Therapeutics Inc. (BCAX) Moving Averages

Dec 27, 2025, 06:03 AM
Period
Simple
Exponential
MA5
17.51Sell
17.38Sell
MA10
17.81Sell
17.68Sell
MA20
18.09Sell
17.71Sell
MA50
16.97Sell
16.89Sell
MA100
14.94Buy
15.57Buy
MA200
13.35Buy
14.26Buy
Bicara Therapeutics Inc.’s (BCAX) 10-Day exponential moving average is 17.68, while Bicara Therapeutics Inc.’s (BCAX) share price is $17.27, making it a Sell.
Bicara Therapeutics Inc.’s (BCAX) 100-Day exponential moving average is 15.57, while Bicara Therapeutics Inc.’s (BCAX) share price is $17.27, making it a Buy.
Bicara Therapeutics Inc.’s (BCAX) stock price is $17.27 and Bicara Therapeutics Inc.’s (BCAX) 50-day simple moving average is 16.97, creating a Sell signal.
Bicara Therapeutics Inc.’s (BCAX) stock price is $17.27 and Bicara Therapeutics Inc.’s (BCAX) 100-day simple moving average is 14.94, creating a Buy signal.
Bicara Therapeutics Inc.’s (BCAX) stock price is $17.27 and Bicara Therapeutics Inc.’s (BCAX) 200-day simple moving average is 13.35, creating a Buy signal.

Bicara Therapeutics Inc. (BCAX) Technical Indicators

Dec 27, 2025, 06:03 AM
Name
Value
Implied Action
RSI (14)
43.72
Neutral
STOCH (9,6)
3.34
Buy
STOCHRSI (14)
3.12
Buy
MACD (12,26)
0.14
Buy
ADX (14)
13.77
Buy
Williams %R
-96.97
Buy
CCI (14)
-173.62
Buy
ATR (14)
1.04
-
Ultimate Oscillator
30.10
Neutral
ROC
-7.69
Sell
Bicara Therapeutics Inc.’s (BCAX) Relative Strength Index (RSI) is 43.72, creating a Neutral signal.
Bicara Therapeutics Inc.’s (BCAX) Trend Strength Indicator (ADX) is 13.77, creating a Buy signal.
Bicara Therapeutics Inc.’s (BCAX) Commodity Channel Index (CCI) is -173.62, creating a Buy signal.
Bicara Therapeutics Inc.’s (BCAX) Price Rate of Change (ROC) is -7.69, creating a Sell signal.

FAQ

Is BCAX a Buy, Hold, or Sell?
Based on BCAX’s technical indicators, BCAX is a Hold.
    What is BCAX’s RSI (14)?
    BCAX’s RSI (14) is 43.72, which suggests BCAX is a Neutral.
      What is BCAX’s MACD?
      BCAX’s MACD is 0.14, which suggests BCAX is a Buy.
        What is BCAX’s 5-day moving average?
        BCAX’s 5-day moving average is 17.51, which suggests BCAX is a Sell.
          What is BCAX’s 20-day moving average?
          BCAX 20-day moving average is 18.09, which suggests BCAX is a Sell.
            What is BCAX’s 50-day moving average?
            BCAX’s 50-day moving average is 16.97, which suggests BCAX is a Sell.
              What is BCAX’s 200-day moving average?
              BCAX’s 200-day moving average is 13.35, which suggests BCAX is a Buy.
                What is BCAX’s Williams % R (14)?
                BCAX’s Williams % R (14) is -96.97, which suggests BCAX is a Buy.
                  What is BCAX’s CCI (14)?
                  BCAX’s CCI (14) is -173.62, which suggests BCAX is a Buy.